April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  

Warning: Trying to access array offset on value of type bool in /var/www/vhosts/oncodaily.com/public_html/pub/themes/oncodailynews/single.php on line 25

Warning: Trying to access array offset on value of type bool in /var/www/vhosts/oncodaily.com/public_html/pub/themes/oncodailynews/single.php on line 26
Feb 24, 2024, 16:34

Chul Kim: What are other relevant targets for ADC therapy in NSCLC?

Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X/Twitter:

What are other relevant targets for Antibody Drug Conjugates (ADCs) therapy in Non-small cell lung cancer (NSCLC)? Farletuzumab ecteribulin (FRalpha), patritumab deruxtecan (HER3), SGN-B6A (integrin beta-6) are being actively investigated. Awesome talk by Maria Antonia Vélez (hematology/oncology fellow at UCLA)!”

Image

Source: Chul Kim/X